BIOMARIN PHARMACEUTICAL INC (BMRN)

(10% Negative) BIOMARIN PHARMACEUTICAL INC (BMRN) Announces Delay in disease Trials for Pompe disease Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment